Supernus Announces Second Quarter 2024 Financial Results
SUPNSupernus Pharmaceuticals(SUPN) GlobeNewswire News Room·2024-08-07 04:06

Net sales of Qelbree® increased 92% in the second quarter of 2024, compared to the same period in 2023. 59.4millionand59.4 million and 104.5 million of net sales in the second quarter and first six months of 2024, respectively. Net sales of GOCOVRI® increased 10% in the second quarter of 2024, compared to the same period in 2023. 31.7 millionand31.7 million and 58.3 million of net sales in the second quarter and first six months of 2024, respectively. Total revenues were $168.3 million in the second quarter of 2024, an increase of ...